Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 39 min ago
PreprintAll rights reservedbioRxiv

A Multi-Kinase Inhibitor Screen Identifies mTOR Signaling as a Vulnerability in Advanced Prostate Cancer.

  • S. Sridhar
  • K. Mohan
  • S. Kizhake
  • A. Natarajan
  • D. L. Kelly
  • G. Mathew1
  1. 1University of Nebraska Medical Center
Read full textPDFDOICite

Related

  1. Clinical Markers of Vulnerability for Bleeding in Men With Prostate Cancer and Antithrombotic Treatment
    Linda Björkhem‐Bergman, Christel Hedman, Máté Szilcz +1
    Cancer reports (Hoboken, N.J.)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. TRPML1 inhibitor ML-SI1 suppresses prostate cancer through dual regulation of androgen receptor and polyamine metabolism
    Jiongzheng Li, Jipeng Ding, Hongfei Wei +6
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Pan-Cancer Analysis Identifies LUC7L2 as a Prognostic Biomarker and Potential Functional Regulator of Prostate Cancer Progression
    Jialin Yuan, Ping Zhan, Jun Liu +4
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Evaluation of FGD3 Expression in Advanced Prostate Cancer
    Bartosz Malinowski, Paulina Antosik, Layla Settaf-Cherif +2
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Perioperative apalutamide in high-risk localized or locally advanced prostate cancer: Is PROTEUS trial practice changing?
    Muhammed Huzaifa
    Indian journal of urology : IJU : journal of the Urological Society of IndiaPeer-reviewedCC BY-NC-SAFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@misc{sridhar2026multikinase,
  title = {{A Multi-Kinase Inhibitor Screen Identifies mTOR Signaling as a Vulnerability in Advanced Prostate Cancer.}},
  author = {S. Sridhar and K. Mohan and S. Kizhake and A. Natarajan and D. L. Kelly and G. Mathew},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.13.758818},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.13.758818v1},
}
RIS
TY  - UNPB
TI  - A Multi-Kinase Inhibitor Screen Identifies mTOR Signaling as a Vulnerability in Advanced Prostate Cancer.
AU  - S. Sridhar
AU  - K. Mohan
AU  - S. Kizhake
AU  - A. Natarajan
AU  - D. L. Kelly
AU  - G. Mathew
PY  - 2026
DA  - 2026/10/13
PB  - bioRxiv
DO  - 10.64898/2026.10.13.758818
UR  - https://www.biorxiv.org/content/10.64898/2026.10.13.758818v1
ER  -